Correction to: The Survival of Advanced Non-small Cell Lung Cancer Patients Treated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Thailand: A Single Institution Review
Archara Supavavej, MD, MSc¹, Manunya Tandhansakul, MD², Prakongboon Sungkasubun, MD, MSc¹, Jomtana Siripaibun, MD¹, Worawit Chaiwiriyawong, MD¹, Teerapat Ungtrakul, MD, MSc³, Wisut Lamlertthon, MD, MPH³
Affiliation : ¹ Medical Oncology Unit, Internal Medicine Department, Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; ² Pediatric Department, Chulabhorn Hospital, Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand; ³ Faculty of medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand
The author has informed the editor to correct the EC number in the article as follow:
Incorrect EC number in the article:
The protocol of this research was reviewed and approved by the Human Research Ethics Committee Chulabhorn Research Institute, No. 029/2561.
Correct EC number:
The protocol of this research was reviewed and approved by the Human Research Ethics Committee Chulabhorn Research Institute, No. 029/2559.
DOI: 10.35755/jmedassocthai.2026.2.04262
Keywords :
